Surgery for subependymal giant cell astrocytomas in children with tuberous sclerosis complex

被引:15
|
作者
Fohlen, Martine [1 ]
Ferrand-Sorbets, Sarah [1 ]
Delalande, Olivier [1 ]
Dorfmueller, Georg [1 ]
机构
[1] Fdn Ophtalmol A de Rothschild, Dept Pediat Neurosurg, Paris, France
关键词
Hydrocephalus; Ventriculoperitoneal shunt; Pediatric; Brain tumor; CONSENSUS CONFERENCE; INTRAVENTRICULAR TUMORS; DIAGNOSTIC-CRITERIA; CORTICAL DYSPLASIAS; RECOMMENDATIONS; MANAGEMENT; IDENTIFICATION; CLASSIFICATION; EVEROLIMUS; SPECTRUM;
D O I
10.1007/s00381-018-3826-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Subependymal giant cell astrocytomas (SEGAs) are low-grade intraventricular glial tumors that develop in 10-15% of patients with tuberous sclerosis complex; they often cause hydrocephalus and are potentially accessible to a surgical treatment. Our aim is to evaluate morbidity and results after surgery in symptomatic and asymptomatic patients. We present a retrospective series of 18 pediatric patients operated on for SEGA between 2006 and 2016 at our institution. We reviewed surgical indications, preoperative clinical and radiologic data, surgical management, and clinical and radiological follow-up. Mean age at surgery was 10.7 years. The surgical decision was based on clinical signs of raised intracranial pressure due to hydrocephalus in 8 and on radiological findings without any clinical signs in the other 10 patients (increased in SEGA volume with or without ventricular enlargement). Surgical treatment consisted in a frontal trans-ventricular microsurgical approach in 17 patients and an endoscopic approach in 1. External ventricular drainage was placed in all the patients but 1. Ventriculoperitoneal shunting (VPS) became necessary in 6 patients, all of them presenting with a preoperative active hydrocephalus. Morbidity appeared very low with meningitis occurring in 1 patient. Resection was complete in 15 children with no recurrence during a mean follow-up of 5.25 years and incomplete in 3 requiring a second surgery. Surgery of SEGA represents a very effective treatment with low morbidity and no mortality in the present series. In patients operated before the onset of clinical signs of hydrocephalus, internal VPS could be avoided whereas in others, an additional shunt surgery became necessary. This gives arguments in favor of a regular MRI surveillance in tuberous sclerosis complex patients with SEGA in order to best propose resective surgery once a growth of tumor and/or ventricular size have been confirmed but before raised intracranial pressure occurs.
引用
收藏
页码:1511 / 1519
页数:9
相关论文
共 50 条
  • [21] Mammalian Target of Rapamycin Inhibitors for Intractable Epilepsy and Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex
    Cardamone, Michael
    Flanagan, Danny
    Mowat, David
    Kennedy, Sean E.
    Chopra, Maya
    Lawson, John A.
    JOURNAL OF PEDIATRICS, 2014, 164 (05) : 1195 - 1200
  • [22] Factors Affecting Response to Everolimus Therapy for Subependymal Giant Cell Astrocytomas Associated With Tuberous Sclerosis
    Trelinska, Joanna
    Dachowska, Iwona
    Kotulska, Katarzyna
    Baranska, Dobromila
    Fendler, Wojciech
    Jozwiak, Sergiusz
    Mlynarski, Wojciech
    PEDIATRIC BLOOD & CANCER, 2015, 62 (04) : 616 - 621
  • [23] Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex
    Franz, David Neal
    BIOLOGICS-TARGETS & THERAPY, 2013, 7 : 211 - 221
  • [24] CLINICAL AND IMMUNOHISTOCHEMICAL STUDIES OF SUBEPENDYMAL GIANT-CELL ASTROCYTOMAS ASSOCIATED WITH TUBEROUS SCLEROSIS
    IWASAKI, Y
    YOSHIKAWA, H
    SASAKI, M
    SUGAI, K
    SUZUKI, H
    HIRAYAMA, Y
    SAKURAGAWA, N
    ARIMA, M
    TAKASHIMA, S
    AOKI, N
    BRAIN & DEVELOPMENT, 1990, 12 (05) : 478 - 481
  • [25] Rapamycin as an alternative to surgical treatment of subependymal giant cell astrocytomas in a patient with tuberous sclerosis complex Case report
    Birca, Ala
    Mercier, Claude
    Major, Philippe
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2010, 6 (04) : 381 - 384
  • [26] Surgical Treatment of Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex Patients
    Kotulska, Katarzyna
    Borkowska, Julita
    Roszkowski, Marcin
    Mandera, Marek
    Daszkiewicz, Pawel
    Drabik, Krzysztof
    Jurkiewicz, Elzbieta
    Larysz-Brysz, Magdalena
    Nowak, Katarzyna
    Grajkowska, Wieslawa
    Domanska-Pakiela, Dorota
    Jozwiak, Sergiusz
    PEDIATRIC NEUROLOGY, 2014, 50 (04) : 307 - 312
  • [27] The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA)
    Weidman, Danielle R.
    Palasamudram, Sunitha
    Zak, Maria
    Whitney, Robyn
    McCoy, Blathnaid
    Bouffet, Eric
    Taylor, Michael
    Shroff, Manohar
    Bartels, Ute
    JOURNAL OF NEURO-ONCOLOGY, 2020, 147 (03) : 731 - 736
  • [28] Natural History and Current Treatment Options for Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex
    Jowiak, Sergiusz
    Mandera, Marek
    Mlynarski, Wojciech
    SEMINARS IN PEDIATRIC NEUROLOGY, 2015, 22 (04) : 274 - 281
  • [29] Presurgical Administration of mTOR Inhibitors in Patients with Large Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex
    Jiang, Tao
    Du, Jiang
    Raynald
    Wang, Junmei
    Li, Chunde
    WORLD NEUROSURGERY, 2017, 107 : 1053.e1 - 1053.e6
  • [30] Neurosurgical treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex: a series of 44 surgical procedures in 31 patients
    Flavio Giordano
    Carla Moscheo
    Matteo Lenge
    Roberto Biagiotti
    Francesco Mari
    Iacopo Sardi
    Anna Maria Buccoliero
    Lorenzo Mongardi
    Eleonora Aronica
    Renzo Guerrini
    Lorenzo Genitori
    Child's Nervous System, 2020, 36 : 951 - 960